Earth Science Tech (ETST) Other Non-Current Liabilities (2024)
Earth Science Tech's (ETST) quarterly Other Non-Current Liabilities came in at $42785.0 in Q4 2024, down 11.82% quarter-over-quarter from $48522.0 in Q3 2024.
Powered by 
Analysis
Earth Science Tech (ETST) Other Non-Current Liabilities (2024) Analysis & Trends
Earth Science Tech (ETST) has reported Other Non-Current Liabilities for 1 consecutive years, with $42785.0 the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Other Non-Current Liabilities changed N/A year-over-year to $42785.0; the trailing twelve-month figure through Dec 2024 stood at $42785.0 (changed N/A YoY), and the FY2024 full-year result was $60559.0, changed N/A from the prior year.
- Other Non-Current Liabilities declined to $42785.0 in Q4 2024 per ETST's latest filing, from $48522.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $60559.0 in Q1 2024 and bottomed at $42785.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | Earth Science Tech | 25.88 Mn | 23.09 Mn | 6.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 42,785.00 |
| Sep 30, 2024 | 48,522.00 |
| Jun 30, 2024 | 54,258.00 |
| Mar 31, 2024 | 60,559.00 |